Is vitamin D deficiency involved in the immune reconstitution inflammatory syndrome?

AIDS Research and Therapy

Volumn 6, Issue , 2009, Pages

  Conesa Botella, Anali ^a,c   Mathieu, Chantal ^b   Colebunders, Robert ^a,c   Moreno Reyes, Rodrigo ^d   van Etten, Evelyne ^b   Lynen, Lut ^a   Kestens, Luc ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CALCITRIOL; PROTEINASE INHIBITOR; VITAMIN D; VITAMIN D BINDING PROTEIN; VITAMIN D RECEPTOR;

ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; DRUG MECHANISM; DRUG SAFETY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INCIDENCE; OSTEOLYSIS; OSTEOPOROSIS; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; SIDE EFFECT; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

EID: 65549085203     PISSN: 17426405     EISSN: None     Source Type: Journal    
DOI: 10.1186/1742-6405-6-4     Document Type: Article

References (46)

1. Egger M May M Chene G Phillips AN Ledergerber B Dabis F et al Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: A collaborative analysis of prospective studies Lancet 2002, 360:119-129. 10.1016/S0140-6736(02)09411-4 12126821
2. Dhasmana DJ Dheda K Ravn P Wilkinson RJ Meintjes G Immune reconstitution inflammatory syndrome in HIV-infected patients receiving antiretroviral therapy: Pathogenesis, clinical manifestations and management Drugs 2008, 68:191-208. 10.2165/00003495-200868020-00004 18197725
3. Murdoch DM Venter WD Feldman C Van RA Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: A prospective study AIDS 2008, 22:601-610. 10.1097/ QAD.0b013e3282f4a607 18317001
4. Meintjes G Lawn SD Scano F Maartens G French MA Worodria W et al Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings Lancet Infect Dis 2008, 8:516-523. 10.1016/S1473-3099(08)70184-1 18652998
5. Colebunders R John L Huyst V Kambugu A Scano F Lynen L Tuberculosis immune reconstitution inflammatory syndrome in countries with limited resources Int J Tuberc Lung Dis 2006, 10:946-953. 16964782
6. Lawn SD Bekker LG Miller RF Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals Lancet Infect Dis 2005, 5:361-373. 10.1016/ S1473-3099(05)70140-7 15919622
7. French MA Disorders of immune reconstitution in patients with HIV infection responding to antiretroviral therapy Curr HIV/AIDS Rep 2007, 4:16-21. 10.1007/s11904-007-0003-z 17338856
8. Norman AW From vitamin D to hormone D: Fundamentals of the vitamin D endocrine system essential for good health Am J Clin Nutr 2008, 88:491S-499S.10. 18689389
9. Tsoukas CD Provvedini DM Manolagas SC 1,25-dihydroxyvitamin D3: A novel immunoregulatory hormone Science 1984, 224:1438-1440. 10.1126/ science.6427926 6427926
10. Kankova M Luini W Pedrazzoni M Riganti F Sironi M Bottazzi B et al Impairment of cytokine production in mice fed a vitamin D3-deficient diet Immunology 1991, 73:466-471. 1384578 1655638
11. Yang S Smith C Prahl JM Luo X DeLuca HF Vitamin D deficiency suppresses cell-mediated immunity in vivo Arch Biochem Biophys 1993, 303:98-106. 10.1006/abbi.1993.1260 8489269
12. Martineau AR Wilkinson RJ Wilkinson KA Newton SM Kampmann B Hall BM et al A single dose of vitamin D enhances immunity to mycobacteria Am J Respir Crit Care Med 2007, 176:208-213. 10.1164/rccm.200701-007OC 17463418
13. Liu PT Stenger S Li H Wenzel L Tan BH Krutzik SR et al Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response Science 2006, 311:1770-1773. 10.1126/science.1123933 16497887
14. Liu PT Stenger S Tang DH Modlin RL Cutting edge: Vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin J Immunol 2007, 179:2060-2063. 17675463
15. Wejse C Olesen R Rabna P Kaestel P Gustafson P Aaby P et al Serum 25-hydroxyvitamin D in a West African population of tuberculosis patients and unmatched healthy controls Am J Clin Nutr 2007, 86:1376-1383. 17991649
16. Villamor E A potential role for vitamin D on HIV infection? Nutr Rev 2006, 64:226-233. 10.1111/j.1753-4887.2006.tb00205.x 16770943
17. Bout-Van Den Beukel Van Den CJ Fievez L Michels M Sweep FC Hermus AR Bosch ME et al Vitamin D deficiency among HIV type 1-infected individuals in the Netherlands: Effects of antiretroviral therapy AIDS Res Hum Retroviruses 2008, 24:1375-1382. 10.1089/aid.2008.0058 18928396
18. Zhou C Assem M Tay JC Watkins PB Blumberg B Schuetz EG et al Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia J Clin Invest 2006, 116:1703-1712. 1459072 16691293 10.1172/JCI27793
19. Tsoukas CD Provvedini DM Manolagas SC 1,25-dihydroxyvitamin D3: A novel immunoregulatory hormone Science 1984, 224:1438-1440. 10.1126/ science.6427926 6427926
20. van Etten E Mathieu C Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts J Steroid Biochem Mol Biol 2005, 97:93-101. 10.1016/ j.jsbmb.2005.06.002 16046118
21. Mathieu C Adorini L The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents Trends Mol Med 2002, 8:174-179. 10.1016/S1471-4914(02)02294-3 11927275
22. Cozzolino M Vidal M Arcidiacono MV Tebas P Yarasheski KE Dusso AS HIV-protease inhibitors impair vitamin D bioactivation to 1,25-dihydroxyvitamin D AIDS 2003, 17:513-520. 10.1097/ 00002030-200303070-00006 12598771
23. Saunders BM Britton WJ Life and death in the granuloma: Immunopathology of tuberculosis Immunol Cell Biol 2007, 85:103-111. 10.1038/ sj.icb.7100027 17213830
24. Kestens L Seddiki N Bohjanen PR Immunopathogenesis of immune reconstitution disease in HIV patients responding to antiretroviral therapy Current Opinion in HIV and AIDS 2009, 3:419-424. 10.1097/ COH.0b013e328302ebbb
25. Burman W Weis S Vernon A Khan A Benator D Jones B et al Frequency, severity and duration of immune reconstitution events in HIV-related tuberculosis Int J Tuberc Lung Dis 2007, 11:1282-1289. 18229435
26. Lawn SD Myer L Bekker LG Wood R Tuberculosis-associated immune reconstitution disease: Incidence, risk factors and impact in an antiretroviral treatment service in South Africa AIDS 2007, 21:335-341. 17255740
27. Navas E Martin-Davila P Moreno L Pintado V Casado JL Fortun J et al Paradoxical reactions of tuberculosis in patients with the acquired immunodeficiency syndrome who are treated with highly active antiretroviral therapy Arch Intern Med 2002, 162:97-99. 10.1001/ archinte.162.1.97 11784229
28. Shelburne SA Visnegarwala F Darcourt J Graviss EA Giordano TP White AC Jr et al Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy AIDS 2005, 19:399-406. 10.1097/01.aids.0000161769.06158.8a 15750393
29. Manabe YC Campbell JD Sydnor E Moore RD Immune reconstitution inflammatory syndrome: Risk factors and treatment implications J Acquir Immune Defic Syndr 2007, 46:456-462. 10.1097/QAI.0b013e3181594c8c 18077835
30. Lips P Vitamin D physiology Prog Biophys Mol Biol 2006, 92:4-8. 10.1016/ j.pbiomolbio.2006.02.016 16563471
31. Holick MF Vitamin D deficiency N Engl J Med 2007, 357:266-281. 10.1056/ NEJMra070553 17634462
32. Loomis WF Skin-pigment regulation of vitamin-D biosynthesis in man Science 1967, 157:501-506. 10.1126/science.157.3788.501 6028915
33. Prosser DE Jones G Enzymes involved in the activation and inactivation of vitamin D Trends Biochem Sci 2004, 29:664-673. 10.1016/ j.tibs.2004.10.005 15544953
34. Baeke F Etten EV Overbergh L Mathieu C Vitamin D3 and the immune system: maintaining the balance in health and disease Nutr Res Rev 2007, 20:106-118. 10.1017/S0954422407742713 19079863
35. Gupta RP He YA Patrick KS Halpert JR Bell NH CYP3A4 is a vitamin D-24- and 25-hydroxylase: Analysis of structure function by site-directed mutagenesis J Clin Endocrinol Metab 2005, 90:1210-1219. 10.1210/ jc.2004-0966 15546903
36. Helming L Bose J Ehrchen J Schiebe S Frahm T Geffers R et al 1alpha,25-Dihydroxyvitamin D3 is a potent suppressor of interferon gamma-mediated macrophage activation Blood 2005, 106:4351-4358. 10.1182/ blood-2005-03-1029 16118315
37. Colin EM Weel AE Uitterlinden AG Buurman CJ Birkenhager JC Pols HA et al Consequences of vitamin D receptor gene polymorphisms for growth inhibition of cultured human peripheral blood mononuclear cells by 1, 25-dihydroxyvitamin D3 Clin Endocrinol (Oxf) 2000, 52:211-216. 10.1046/ j.1365-2265.2000.00909.x 10671949
38. Overbergh L Decallonne B Valckx D Verstuyf A Depovere J Laureys J et al Identification and immune regulation of 25-hydroxyvitamin D-1-alphahydroxylase in murine macrophages Clin Exp Immunol 2000, 120:139-146. 1905630 10759775 10.1046/j.1365-2249.2000.01204.x
39. Lawn SD Macallan DC Hypercalcemia: A manifestation of immune reconstitution complicating tuberculosis in an HIV-infected person Clin Infect Dis 2004, 38:154-155. 10.1086/380451 14679464
40. Ferrand RA Elgalib A Newsholme W Childerhouse A Edwards SG Miller RF Hypercalcaemia complicating immune reconstitution in an HIV-infected patient with disseminated tuberculosis Int J STD AIDS 2006, 17:349-350. 10.1258/095646206776790169 16643687
41. Shelburne SA III Hamill RJ Rodriguez-Barradas MC Greenberg SB Atmar RL Musher DW et al Immune reconstitution inflammatory syndrome: Emergence of a unique syndrome during highly active antiretroviral therapy Medicine (Baltimore) 2002, 81:213-227. 10.1097/00005792-200205000-00005 11997718
42. Jenny-Avital ER Abadi M Immune reconstitution cryptococcosis after initiation of successful highly active antiretroviral therapy Clin Infect Dis 2002, 35:e128-e133. 10.1086/344467 12471589
43. Madeddu G Spanu A Solinas P Calia GM Lovigu C Chessa F et al Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy Q J Nucl Med Mol Imaging 2004, 48:39-48. 15195003
44. Rivas P Gorgolas M Garcia-Delgado R az-Curiel M Goyenechea A Fernandez-Guerrero ML Evolution of bone mineral density in AIDS patients on treatment with zidovudine/lamivudine plus abacavir or lopinavir/ ritonavir HIV Med 2008, 9:89-95. 10.1111/j.1468-1293.2007.00525.x 18093130
45. Brown TT Qaqish RB Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: A meta-analytic review AIDS 2006, 20:2165-2174. 10.1097/QAD.0b013e32801022eb 17086056
46. Holick MF Vitamin D status: Measurement, interpretation, and clinical application Ann Epidemiol 2009, 19:73-78. 10.1016/ j.annepidem.2007.12.001 18329892